Preferred Label : Pompe disease;
CISMeF acronym : AMD; GSD II; GSD2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Cardiomegalia glycogenica diffusa; Acid maltase deficiency; AMD; GSD2; Alpha-1,4-glucosidase deficiency; Gsd II; Glycogenosis, generalized, cardiac form; Acid alpha-glucosidase deficiency; Gaa deficiency; Glycogen storage disease II;
Description : Glycogen storage disease II, an autosomal recessive disorder, is the prototypic lysosomal
storage disease. In the classic infantile form (Pompe disease), cardiomyopathy and
muscular hypotonia are the cardinal features; in the juvenile and adult forms, involvement
of skeletal muscles dominates the clinical picture Matsuishi et al. (1984).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the alpha-1,4-glucosidase gene (GAA, 606800.0002);
Laboratory abnormalities : Elevated serum creatine kinase; Elevated AST and LDH, especially infantile-onset; Presence of vacuoles on muscle biopsy; Deficiency of alpha-1,4-glucosidase (acid maltase);
Prefixed ID : #232300;
Origin ID : 232300;
UMLS CUI : C0017921;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT